There are several theories of the pathogenesis of urate 2 accumulation in patients with gout. A disturbance of elimination of this substance by the kidneys is probably the most popular. This has been challenged, however, in a previous communication from this laboratory (1), since it appears to be inconsistent with certain experimental data. Whether or not this theory is valid, it deserves serious consideration because urates as naturally occurring end-products of purine metabolism are disposed of by the body largely by excretion through the kidneys. If one pursues the hypothesis to a logical conclusion, any defect of elimination might be inherited or it might be an acquired phenomenon following damage to the functioning units of the kidneys.
There are several theories of the pathogenesis of urate 2 accumulation in patients with gout. A disturbance of elimination of this substance by the kidneys is probably the most popular. This has been challenged, however, in a previous communication from this laboratory (1) , since it appears to be inconsistent with certain experimental data. Whether or not this theory is valid, it deserves serious consideration because urates as naturally occurring end-products of purine metabolism are disposed of by the body largely by excretion through the kidneys. If one pursues the hypothesis to a logical conclusion, any defect of elimination might be inherited or it might be an acquired phenomenon following damage to the functioning units of the kidneys.
The accepted theory (2, 3) of renal physiology in man assumes that urates are present in glomerular urine as are other ultrafiltrable substances and reabsorbed in part by the cells lining the tubules. If the kidneys were primarily at fault in the gouty diathesis, accumulation of urate might be attributed either to (a) a reduction of the number of functioning glomeruli or (b) an increased reabsorption by the tubules. Both of these phenomena are partially susceptible of quantitative analysis now that improved methods for the study of kidney function are available.
A presentation and discussion of kidney function data, as determined by five experimental procedures, are contained in this communication. These include tests for the excretion of substances normally present in the body such as urea, creatinine, urate, sodium and chloride and for the excretion of foreign substances introduced parenterally such as phenolsulphonphthalein, neo-iopax and inulin. Studies were made of normal persons and of patients suffering from diseases other than gout, as well as of patients with classical gout. The action of drugs used therapeutically in the treatment of acute and chronic gouty arthritis was investigated.
SUBJECTS
Thirty-one persons acted as experimental subjects. Twenty-two were afflicted with gout; six were patients with diseases other than gout; three were normal persons. The patients with gout were selected without regard to extent of disease or duration of symptoms. It was necessary only that the criteria for the diagnosis of gout were satisfied (1, 4, 5) and that the patients consented to hospital admission for study. All except K. He. were males. Their ages varied from 28 to 81 years. Each patient had had two or more attacks of acute arthritis, and on two or more occasions the concentration of fasting serum urate had been greater than 6.0 mgm. per 100 cc. Osseous or cartilagenous tophi were suspected from the roentgenogram in thirteen. Subcutaneous tophi were present in seventeen. All the patients seen during an acute attack of arthritis had responded to full doses of colchicine. Renal stones, composed largely of urates, had been passed by seven. A summary of the clinical data for each patient with gout is given in Table I . Several of the patients have been described in previous communications (1, 6, 7) . Identical initials refer to the same patient. Four men and four women, none of whom showed impairment of kidney function, acted as controls. Their ages varied from 20 to 54 years. A normal inulin clearance (greater than 95 cc. per minute) and a concentration of fasting serum urate less than 6.0 mgm. per 100 cc. were observed in each control subject. One woman with advanced Bright's disease and malignant hypertension completed the group of controls.
METHODS
All of the data were collected while the subjects were in the metabolism ward of the Massachusetts General Hospital. The patients with gout were allowed, during the period of observation, a low-purine diet containing about 70 grams of protein, 90 grams of fat and 300 grams of carbohydrate. The control subjects consumed the usual hospital diet which was moderately low in purine. The July 1, 1938 , urine concentration tests were done by a slight modification of the overnight method described by Fishberg (8) . We have arbitrarily set 1.022 as the lower limit of normal. After this time, except for I. Co., S. Co., and J. Sm., the "37-hour test" (9) was used. Correction of specific gravity for albumin was made. Under these conditions normally functioning kidneys are able to concentrate to a specific gravity greater than 1.028. Fractional phenolsulphonphthalein tests were done according to the method described by Chapman and Halsted (10). Intravenous pyelography followed the standard technique.
Clearance tests for inulin, creatinine and urate, and in some patients sodium and chloride, were performed simultaneously. The procedure outlined by Shannon and Smith (11) (14) by the difference in the concentration of reducing substances before and after acid-hydrolysis (15) . Creatinine was determined according to the method described by Folin and Wu (16) ; urate according to the method described by Benedict and Behre (17) ; sodium according to the method described by Butler and Tuthill (18) . Serum chloride was determined according tp the method described by Keys (19) and urine chloride according to the method described by Harvey (20) .
EXPERIMENTAL RESULTS
Inulin and creatinine clearance and routine clinical tests The patients with gout (Table II) There were nine patients in Group I. Their ages varied from 28 to 59 years. All except H. Wa. had a systolic blood pressure below 150 and a diastolic pressure below 100 mm. Hg. The blood pressure of H. Wa. was 160/90. Four patients only, E. Dw., S. Co., M. Co., and I. Co., were able to excrete a urine with a specific gravity of 1.022 or greater in the overnight test. F. To. was unable to reach the minimum normal level of 1.029 in the " 37-hour test." All except L. Mu. excreted more than 25 per cent phenolsulphonphthalein dye within 15 minutes after injection. The serum nonprotein nitrogen was less than 35 mgm. per 100 cc. in all patients. Intravenous pyelography was performed in all except E. Dw. The excretion of neo-iopax was prompt in each instance. Patient H. Wa. showed kidney shadows which were believed to be smaller than normal. According to his history he probably had had a mild attack of Bright's disease ( ? acute glomerular nephritis) as a young man. P. Le. had had a urate stone removed from the left kidney pelvis one month before admission to the metabolism ward. The finding of an indistinct pelvis on the left has been attributed to trauma at operation and subsequent diminution in capacity. Thus, while all patients in this group showed normal kidney function by the inulin and creatinine clearance tests, only four showed normal function by all of the tests. Inability to concentrate urine maximally appears to be the first indication of renal impairment in patients with gout.
There were nine patients in Group II. Their ages varied from 31 to 81 years. Five patients, W. G. B., P. Fa., L. Si., F. Na., and J. Sm., had a normal blood pressure. Two of the remaining four, J. Go., and A. Cas., with slight and moderate elevation of systolic pressure, respectively, had had attacks of hypertensive encephalopathy and elevation of systolic blood pressure over 200 mm. Hg. All patients showed an inability to concentrate urine maximally. The specific gravities ranged from 1.018 to 1.009. Only three patients, P. Fa., J. Go., and F. Na., were (Table III) was the only control studied who had terminal Bright's disease. The urate clearance on this patient was 7.5 cc. per minute. More than 88 per cent of the filtered urate was excreted in the urine and less than 12 per cent was reabsorbed.
The relationship between inulin clearance and percentage tubular reabsorption of urate is shown in Figure 1 . It is apparent that progressive renal damage in gouty as well as in non-gouty patients is associated with an increase in urate excretion relative to glomerular filtration. The percentage reabsorption of urates by the tubules is not depressed, however, until the inulin clearance is decreased below 50 cc. per minute or approximately one-half of the normal rate. Only when glomerular filtration is reduced to a negligible amount does retention of urate from failure of renal excretion assume pathological significance.
Action of drugs
The effects of cinchophen in therapeutic amounts -on the clearance of inulin, urate, sodium and chloride are given in Table IV . Two grams of cinchophen were given orally in divided doses on the day before the clearance tests were done and an additional dose of 0.5 gram each was given at 6:00 and 7:00 on the morning of the test. The clearances of inulin, sodium, and chloride were un- (25, 26, 27) . The constancy of the results by the 5 methods employed is satisfactory. Eighteen of the twenty-two patients in Table II show some limitation of renal function. The inability to concentrate solids maximally (28) appears to be the first evidence of failure. In Group I, five patients with normal inulin and creatinine clearance rates were unable to concentrate maximally. In Group II, each patient had a lowered specific gravity. All of the patients in Group III showed renal deterioration by each of the tests. As an approximation, it may be st-ated that neither duration of symptoms of gouty arthritis nor degree of elevation of serum urate are the sole determining factors in producing renal dysfunction. It is noteworthy that the age of the patient appears to be of secondary importance and longevity may not be impaired.
Hypertension and arteriosclerosis have been associated with a reduction in kidney function (29) in various maladies. It is pertinent, therefore, to consider their incidence in patients with gout. In our series only eight had hypertension; in each of these it corresponded to the benign rather than the malignant type (30) . K. He. developed hypertension under observation but not until 3 years after laboratory tests was there severe impairment of renal function. She had recurring cystitis and mild pyelonephritis, factors which probably contributed to the hypertension. A. Ca., on the other hand, also had had cystitis but at no examination was hypertension noted. A. De. had bilateral renal stones and a systolic blood pressure of 170 mm. Hg. The other patients with hypertension gave no history of urinary tract infection nor did they have any signs or symptoms suggesting it. The development of arteriosclerosis in patients with gout occurs probably earlier than hypertension. All of the patients in Group II, which includes F. Na., a man of 31, had sclerosis of the peripheral arteries. Two of the four in Group III, A. Ca. and A. De., showed similar changes. Each of the three who were studied at necropsy, J. Sm., A. Cas. and A. Ca., had renal arteriosclerosis. The narrowing of the lumina of the vessels in each patient was believed to have been sufficient to have reduced the blood flow through the kidneys. Evidence of interference with the blood supply to the tubules through the afferent glomerular vessels was seen in the microscopic sections from A. Ca. In J. Sm. and A. Cas. the large renal vessels showed similar changes. It seems reasonable, therefore, to attribute a portion of the reduction in kidney function in these patients to reduced blood flow (31, 32) . In sixteen out of eighteen patients who died with gout, Brogsitter (27) observed a systolic blood pressure greater than 170 and a diastolic greater than 104. Since his observations were collected late in the course of the disease, we conclude that, if hypertension occurs in gout, it is a late manifestation secondary to prolonged renal damage and diminished renal flow.
The deposition of urates in the kidney parenchyma may be significant in the production of renal deterioration. In each of the kidneys which was studied at necropsy urates were visible grossly and microscopically. The medullary portions showed the most extensive deposits. In J. Sm. and A. Ca. the collecting tubules showed many small urate calculi. Most of these would be passed without producing symptoms of urinary tract obstruction; it might be the fate of others to develop into larger urate calculi. Obstruction and infection are possible sequellae.
The term nephritis has been avoided purposely in this discussion. The pathological diagnosis in the three patients studied at necropsy was chronic vascular nephritis. One should not quarrel about an anatomical diagnosis. The use of the term gouty nephritis in describing renal insufficiency in patients with gout is more hazardous. Many retain the term for late manifestations. Our data show that most patients with gout have some impairment of renal function. It is likely that the impairment is irreparable, although the progression appears to be very slow. A better term than gouty nephritis would be " renal impairment of gout" which carries with it no special etiologic implications.
The term urate clearance has been employed rather freely in this discussion. It implies and embodies a process similar to the clearance of other substances which are excreted by the kidneys. Inherent aspects of urate clearance include appearance of urates in glomerular filtrate in approximately the same concentration as they exist in plasma, and absorption in part by contiguous cells as the glomerular filtrate passes through the tubular lumina. This theory assumes that excretion of urates by the tubules does not occur. The elimination of urates by the kidney is of more than academic interest and once correctly defined possesses considerable etiologic significance. Future thinking and investigation concerning the etiology of gout will not be definitive until it is settled as to whether or not the kidneys are responsible for the accumulation of urates in patients with this malady. It was hoped that this study would help in the solution of the problem. That it has done but it has not clinched the argument. It is believed that our data show no differential inability of the kidneys to clear urate in gouty patients. This conclusion, however, is based upon certain assumptions, the proof for which is not yet available.
The urate clearance data of Berglund and Frisk (33) The second interpretation utilizes the hypothesis advanced by Hayman et al (13) . They have suggested that the failure of reabsorption of urea in dogs with damaged kidneys may be attributed to increased urine flow through the tubules. It is possible that retarded reabsorption of urate in patients with impaired kidneys may be explained similarly. The abnormal data may represent the average of the combined filtration and reabsorption of normal and partially damaged nephrons.
In discussing this subject with Dr. S. J. Thannhauser, he has called our attention to yet a third interpretation. If urates were excreted in part by the tubules, similar data might be obtained. This assumption is plausible if the premise were correct, i.e. urates are excreted by the tubules. We believe that direct evidence in mammals and indirect evidence in man'does not support this premise and that the explanation, therefore, must be held in abeyance for the present.
The action of drugs on renal function concludes the discussion. 
